These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 34735975)
1. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma. Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975 [TBL] [Abstract][Full Text] [Related]
2. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
4. The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma. Wang W; Shen C; Zhao Y; Sun B; Qiu X; Yin S; Chen J; Li X Front Cell Dev Biol; 2021; 9():719820. PubMed ID: 35047491 [TBL] [Abstract][Full Text] [Related]
5. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer. Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635 [TBL] [Abstract][Full Text] [Related]
6. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database. Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the prognostic significance and potential mechanisms of lncRNAs related to m6A methylation in laryngeal cancer. Cen J; Wang L; Zhang H; Guo Y Biotechnol Genet Eng Rev; 2024 Nov; 40(3):2129-2154. PubMed ID: 37053494 [TBL] [Abstract][Full Text] [Related]
9. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955 [TBL] [Abstract][Full Text] [Related]
10. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Liu Y; Wang T; Fang Z; Kong J; Liu J J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871 [TBL] [Abstract][Full Text] [Related]
11. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer. Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405 [TBL] [Abstract][Full Text] [Related]
12. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
13. Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs. Hu B; Lin D; Liu Z; Chen R; Liu J; Wu Y; Wang T Eur J Med Res; 2024 Aug; 29(1):411. PubMed ID: 39118157 [TBL] [Abstract][Full Text] [Related]
14. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer. Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112 [TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma. Wang Y; Li X; Huang Y; Gang Q; Liu M; Zhang H; Shen S; Qi Y; Zhang J J Inflamm Res; 2024; 17():1995-2008. PubMed ID: 38566983 [TBL] [Abstract][Full Text] [Related]
16. m6A- and m5C- modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A- modified LINC00893 regulates cutaneous melanoma cell metastasis. Shi HZ; Tian CC; Wu MY; Ma L; Sun JF; Chen H Skin Res Technol; 2024 Jul; 30(7):e13842. PubMed ID: 38965799 [TBL] [Abstract][Full Text] [Related]
17. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram. Chen F; Li Z; Deng C; Yan H J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223 [TBL] [Abstract][Full Text] [Related]
18. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer. Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790 [TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer. Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477 [TBL] [Abstract][Full Text] [Related]
20. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]